{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:04:59Z","timestamp":1793851499964,"version":"4.6.1"},"reference-count":297,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174314, 82474255"],"award-info":[{"award-number":["82174314, 82474255"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The dynamic balance between T helper 17 (Th17) cells and regulatory T (Treg) is the cornerstone of immune homeostasis. Disruption of this equilibrium is closely associated with various autoimmune diseases, including rheumatoid arthritis (RA), multiple sclerosis (MS), and inflammatory bowel disease (IBD). Studies have revealed that metabolic reprogramming, mediated by key metabolic enzymes (including mTOR, HIF-1\u03b1, and AMPK) and pathways (such as glycolysis and lipid metabolism), acts as a major regulator of Th17\/Treg differentiation and function owing to their distinct metabolic profiles. Metabolic dysregulation may exacerbate immune imbalance by altering the cellular differentiation trajectories and functional states. Although targeting metabolic pathways shows therapeutic promise, current intervention strategies face challenges in terms of specificity and safety. This review systematically combs the mechanisms by which metabolic reprogramming influences the differentiation and function of Th17\/Treg cells, as well as the metabolic changes in immune cells of inflammation-related autoimmune diseases. It outlines the progress of the latest metabolism-targeted strategies and focuses on discussing the challenges and prospects regarding the specificity and safety of metabolic interventions.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1687755","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T05:17:40Z","timestamp":1765862260000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Metabolic reprogramming as a therapeutic target for modulating the Th17\/Treg balance in autoimmune diseases: a comprehensive review"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuehong","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053019","article-title":"Unraveling the complex interplay between T cell metabolism and function","volume":"36","author":"Klein Geltink","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41577-019-0203-y","article-title":"Metabolic coordination of T cell quiescence and activation","volume":"20","author":"Chapman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-095956","article-title":"Metabolic regulation of T lymphocytes","volume":"31","author":"MacIver","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nri.2017.99","article-title":"The spectrum of T cell metabolism in health and disease","volume":"18","author":"Bantug","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.07.004","article-title":"Post-translational regulation of ROR\u03b3t\u2014A therapeutic target for the modulation of interleukin-17-mediated responses in autoimmune diseases","volume":"30","author":"Rutz","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1663","article-title":"Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells","volume":"9","author":"Zhang","year":"2008","journal-title":"Nat Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3748","article-title":"The transcriptional coactivator TAZ regulates reciprocal differentiation of TH17 cells and Treg cells","volume":"18","author":"Geng","year":"2017","journal-title":"Nat Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00893-7","article-title":"The role of transcription factors in shaping regulatory T cell identity","volume":"23","author":"Trujillo-Ochoa","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-00994-x","article-title":"The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases","volume":"24","author":"Sumida","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/imm.13178","article-title":"Control of regulatory T-cell differentiation and function by T-cell receptor signalling and Foxp3 transcription factor complexes","volume":"160","author":"Ono","year":"2020","journal-title":"Immunology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0900408106","article-title":"Identification of IL-17-producing FOXP3+ regulatory T cells in humans","volume":"106","author":"Voo","year":"2009","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.1038\/s41467-018-07254-2","article-title":"Inflammation-induced Id2 promotes plasticity in regulatory T cells","volume":"9","author":"Hwang","year":"2018","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","first-page":"20675","DOI":"10.1038\/s41598-022-24924-w","article-title":"Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3intCD161\u2009+\u2009ROR\u03b3t\u2009+\u2009ICOS\u2009+\u2009phenotype, that associates with the presence of ADAMTSL5 autoantibodies","volume":"12","author":"Pouw","year":"2022","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0120-4","article-title":"Regulatory T cells in autoimmune diseases","volume":"19","author":"Dominguez-Villar","year":"2018","journal-title":"Nat Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1621396","article-title":"Treg cell plasticity as a driver of inflammation in spondyloarthritis and psoriasis","volume":"16","author":"Ortega-Mejia","year":"2025","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nature06878","article-title":"TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function","volume":"453","author":"Zhou","year":"2008","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-019-00733-8","article-title":"The pathogenicity of Th17 cells in autoimmune diseases","volume":"41","author":"Yasuda","year":"2019","journal-title":"Semin Immunopathol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","article-title":"Transforming growth factor-beta regulation of immune responses","volume":"24","author":"Li","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/ni1539","article-title":"TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology","volume":"8","author":"McGeachy","year":"2007","journal-title":"Nat Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nature09447","article-title":"Generation of pathogenic th17 cells in the absence of TGF-\u03b2 Signaling","volume":"467","author":"Ghoreschi","year":"2010","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2416","article-title":"Induction and molecular signature of pathogenic TH17 cells","volume":"13","author":"Lee","year":"2012","journal-title":"Nat Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.11.009","article-title":"Single-cell genomics unveils critical regulators of th17 cell pathogenicity","volume":"163","author":"Gaublomme","year":"2015","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2021.09.005","article-title":"ROR\u03b3t protein modifications and IL-17-mediated inflammation","volume":"42","author":"Kumar","year":"2021","journal-title":"Trends Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-022-01387-9","article-title":"TH17 cell heterogeneity and its role in tissue inflammation","volume":"24","author":"Schnell","year":"2023","journal-title":"Nat Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20060285","article-title":"A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis","volume":"203","author":"Sutton","year":"2006","journal-title":"J Exp Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2009.03.001","article-title":"Transcriptional regulatory networks in Th17 cell differentiation","volume":"21","author":"Zhou","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J Exp Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1698","article-title":"The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo","volume":"10","author":"McGeachy","year":"2009","journal-title":"Nat Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.02.007","article-title":"Critical regulation of early Th17 cell differentiation by interleukin-1 signaling","volume":"30","author":"Chung","year":"2009","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/imr.12035","article-title":"The Th17 family: flexibility follows function","volume":"252","author":"Basu","year":"2013","journal-title":"Immunol Rev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2007.10.011","article-title":"Transcriptional regulation of Th17 cell differentiation","volume":"19","author":"Ivanov","year":"2007","journal-title":"Semin Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.7.4785","article-title":"Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3","volume":"180","author":"Du","year":"2008","journal-title":"J Immunol Baltim Md"},{"key":"B34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","article-title":"Molecular antagonism and plasticity of regulatory and inflammatory T cell programs","volume":"29","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"B35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/ni.1965","article-title":"Control of regulatory T cell and Th17 cell differentiation by inhibitory helix-loop-helix protein Id3","volume":"12","author":"Maruyama","year":"2011","journal-title":"Nat Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.08.012","article-title":"Induced regulatory T cells: their development, stability, and applications","volume":"37","author":"Kanamori","year":"2016","journal-title":"Trends Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.02.009","article-title":"Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation","volume":"26","author":"Laurence","year":"2007","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imr.12160","article-title":"tTregs, pTregs, and iTregs: similarities and differences","volume":"259","author":"Shevach","year":"2014","journal-title":"Immunol Rev"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20151438","article-title":"Control of Foxp3 stability through modulation of TET activity","volume":"213","author":"Yue","year":"2016","journal-title":"J Exp Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502352","article-title":"Vitamin C facilitates demethylation of the foxp3 enhancer in a tet-dependent manner","volume":"196","author":"Nair","year":"2016","journal-title":"J Immunol Baltim Md"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.12.8209","article-title":"Cutting edge: antigen-specific TGF\u03b2-induced regulatory T cells suppress th17-mediated autoimmune disease1","volume":"181","author":"Huter","year":"2008","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-015-0344-z","article-title":"The role of IL-17 and th17 lymphocytes in autoimmune diseases","volume":"63","author":"Tabarkiewicz","year":"2015","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.53","article-title":"The IL-23\u2013IL-17 axis in inflammatory arthritis","volume":"11","author":"Lubberts","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2009.10.012","article-title":"IL-23 induces receptor activator of NF-\u03baB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-\u03baB signal pathways","volume":"127","author":"Li","year":"2010","journal-title":"Immunol Lett"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.22326","article-title":"IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-alpha antibody: a novel mechanism of osteoclastogenesis by IL-17","volume":"108","author":"Yago","year":"2009","journal-title":"J Cell Biochem"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.10.090","article-title":"Reciprocal expression of IL-35 and IL-10 defines two distinct effector treg subsets that are required for maintenance of immune tolerance","volume":"21","author":"Wei","year":"2017","journal-title":"Cell Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2023739118","article-title":"Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory t cells","volume":"185","author":"Mezrich","year":"2010","journal-title":"J Immunol Baltim Md"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1126\/science.1172702","article-title":"CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner","volume":"326","author":"Chaudhry","year":"2009","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.09.007","article-title":"Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine","volume":"43","author":"Haghikia","year":"2015","journal-title":"Immunity"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.7150\/thno.43716","article-title":"Parthenolide ameliorates colon inflammation through regulating Treg\/Th17 balance in a gut microbiota-dependent manner","volume":"10","author":"Liu","year":"2020","journal-title":"Theranostics"},{"key":"B52","doi-asserted-by":"publisher","first-page":"133794","DOI":"10.1016\/j.ijbiomac.2024.133794","article-title":"Synbiotics containing sea buckthorn polysaccharides ameliorate DSS-induced colitis in mice via regulating Th17\/Treg homeostasis through intestinal microbiota and their production of BA metabolites and SCFAs","volume":"276","author":"Yuan","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2402547","DOI":"10.1080\/19490976.2024.2402547","article-title":"Prebiotic inulin controls Th17 cells mediated central nervous system autoimmunity through modulating the gut microbiota and short chain fatty acids","volume":"16","author":"Li","year":"2024","journal-title":"Gut Microbes"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00551","article-title":"Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research","volume":"5","author":"Nguyen","year":"2014","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-024-01286-z","article-title":"Inhibition of BCAT1-mediated cytosolic leucine metabolism regulates Th17 responses via the mTORC1-HIF1\u03b1 pathway","volume":"56","author":"Kang","year":"2024","journal-title":"Exp Mol Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.07.033","article-title":"Control of TH17\/treg balance by hypoxia-inducible factor 1","volume":"146","author":"Dang","year":"2011","journal-title":"Cell"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110278","article-title":"HIF1\u03b1\u2013dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells","volume":"208","author":"Shi","year":"2011","journal-title":"J Exp Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2007.01786.x","article-title":"Glucose transporter expression on the plasma membrane of resting and activated white blood cells","volume":"37","author":"Maratou","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-108050","article-title":"CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85\/p110 heterodimer","volume":"111","author":"Gar\u00e7on","year":"2008","journal-title":"Blood"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(02)00323-0","article-title":"The CD28 signaling pathway regulates glucose metabolism","volume":"16","author":"Frauwirth","year":"2002","journal-title":"Immunity"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.7.4476","article-title":"Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways","volume":"180","author":"Jacobs","year":"2008","journal-title":"J Immunol Baltim Md"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01632","article-title":"Metabolism controls the balance of th17\/T-regulatory cells","volume":"8","author":"Sun","year":"2017","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.2AB0514-273RR","article-title":"Foxp3-mediated inhibition of Akt inhibits Glut1 (glucose transporter 1) expression in human T regulatory cells","volume":"97","author":"Basu","year":"2015","journal-title":"J Leukoc Biol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3577","article-title":"Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression","volume":"17","author":"Gerriets","year":"2016","journal-title":"Nat Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cmet.2022.02.015","article-title":"The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming","volume":"34","author":"Hochrein","year":"2022","journal-title":"Cell Metab"},{"key":"B66","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","article-title":"The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function","volume":"20","author":"Macintyre","year":"2014","journal-title":"Cell Metab"},{"key":"B67","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cmet.2019.10.015","article-title":"Pharmacological activation of pyruvate kinase M2 inhibits CD4+ T cell pathogenicity and suppresses autoimmunity","volume":"31","author":"Angiari","year":"2020","journal-title":"Cell Metab"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.127395","article-title":"Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation","volume":"4","author":"Kono","year":"2019","journal-title":"JCI Insight"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190613","article-title":"PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation","volume":"217","author":"Damasceno","year":"2020","journal-title":"J Exp Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"155973","DOI":"10.1016\/j.phymed.2024.155973","article-title":"Aucklandiae radix targeted PKM2 to alleviate ulcerative colitis: Insights from the photocrosslinking target fishing technique","volume":"134","author":"Feng","year":"2024","journal-title":"Phytomedicine"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4328","article-title":"Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction","volume":"23","author":"Qi","year":"2017","journal-title":"Nat Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13045-017-0392-4","article-title":"NEK2 promotes aerobic glycolysis in multiple myeloma through regulating splicing of pyruvate kinase","volume":"10","author":"Gu","year":"2017","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41420-025-02403-1","article-title":"Metabolic reprogram and T cell differentiation in inflammation: current evidence and future perspectives","volume":"11","author":"Shi","year":"2025","journal-title":"Cell Death Discov"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a002436","article-title":"An enigmatic tail of CD28 signaling","volume":"2","author":"Boomer","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2017.04.005","article-title":"mTOR signaling in the differentiation and function of regulatory and effector T cells","volume":"46","author":"Zeng","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.932893","article-title":"Obesity-mediated immune modulation: one step forward, (Th)2 steps back","volume":"13","author":"Schmidt","year":"2022","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ni.2005","article-title":"The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nat Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.11.024","article-title":"An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness","volume":"33","author":"Procaccini","year":"2010","journal-title":"Immunity"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1901480","article-title":"Regulatory T cell stability and migration are dependent on mTOR","volume":"205","author":"Vallion","year":"2020","journal-title":"J Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2017.04.004","article-title":"The role of AMPK in T cell metabolism and function","volume":"46","author":"Ma","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nat Cell Biol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201600522R","article-title":"The AMP analog AICAR modulates the Treg\/Th17 axis through enhancement of fatty acid oxidation","volume":"30","author":"Gualdoni","year":"2016","journal-title":"FASEB J"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0604708103","article-title":"A pivotal role for endogenous TGF-\u03b2-activated kinase-1 in the LKB1 AMP-activated protein kinase energy-sensor pathway","volume":"103","author":"Xie","year":"2006","journal-title":"Med Sci"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202001763RR","article-title":"The energy sensor AMPK orchestrates metabolic and translational adaptation in expanding T helper cells","volume":"35","author":"Mayer","year":"2021","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00099","article-title":"Environmental and metabolic sensors that control T cell biology","volume":"6","author":"Ramsay","year":"2015","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00698","article-title":"Th17 polarization under hypoxia results in increased IL-10 production in a pathogen-independent manner","volume":"8","author":"Volchenkov","year":"2017","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838318","article-title":"Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1\u03b1","volume":"38","author":"Ben-Shoshan","year":"2008","journal-title":"Eur J Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202366109","article-title":"Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa","volume":"109","author":"Clambey","year":"2012","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B89","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/imm.12388","article-title":"Hypoxic culture conditions enhance the generation of regulatory T cells","volume":"144","author":"Neildez-Nguyen","year":"2015","journal-title":"Immunology"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J Immunol Baltim Md"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-022-01017-3","article-title":"Lipid metabolism in T cell signaling and function","volume":"18","author":"Lim","year":"2022","journal-title":"Nat Chem Biol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-019-0356-x","article-title":"T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy","volume":"16","author":"Sharabi","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/nature08530","article-title":"Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43","volume":"461","author":"Maslowski","year":"2009","journal-title":"Nature"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1172\/JCI138519","article-title":"Oleic acid restores suppressive defects in tissue-resident FOXP3 Tregs from patients with multiple sclerosis","volume":"131","author":"Pompura","year":"2021","journal-title":"J Clin Invest"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control TH17 and Treg cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1865-0","article-title":"Microbial bile acid metabolites modulate gut ROR\u03b3+ regulatory T cell homeostasis","volume":"577","author":"Song","year":"2020","journal-title":"Nature"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04480-z","article-title":"Human gut bacteria produce \u03c4\u03b717-modulating bile acid metabolites","volume":"603","author":"Paik","year":"2022","journal-title":"Nature"},{"key":"B99","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41573-021-00367-2","article-title":"Lipogenesis inhibitors: therapeutic opportunities and challenges","volume":"21","author":"Batchuluun","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3704","article-title":"De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells","volume":"20","author":"Berod","year":"2014","journal-title":"Nat Med"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.07.014","article-title":"Obesity drives th17 cell differentiation by inducing the lipid metabolic kinase, ACC1","volume":"12","author":"Endo","year":"2015","journal-title":"Cell Rep"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2014.12.005","article-title":"Fatty acid metabolism in the regulation of T cell function","volume":"36","author":"Lochner","year":"2015","journal-title":"Trends Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","article-title":"The biochemistry and physiology of mitochondrial fatty acid \u03b2-oxidation and its genetic disorders","volume":"78","author":"Houten","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"973986","DOI":"10.1155\/2014\/973986","article-title":"Metformin attenuates experimental autoimmune arthritis through reciprocal regulation of Th17\/treg balance and osteoclastogenesis","volume":"2014","author":"Son","year":"2014","journal-title":"Mediators Inflammation"},{"key":"B105","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-022-01322-3","article-title":"Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity","volume":"15","author":"Yan","year":"2022","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"101055","DOI":"10.1016\/j.plipres.2020.101055","article-title":"Lipids in the tumor microenvironment: from cancer progression to treatment","volume":"80","author":"Corn","year":"2020","journal-title":"Prog Lipid Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12388","article-title":"Foxp3 drives oxidative phosphorylation and protection from lipotoxicity","volume":"2","author":"Howie","year":"2017","journal-title":"JCI Insight"},{"key":"B108","doi-asserted-by":"publisher","first-page":"102709","DOI":"10.1016\/j.redox.2023.102709","article-title":"Mitochondrial fusion induced by transforming growth factor-\u03b21 serves as a switch that governs the metabolic reprogramming during differentiation of regulatory T cells","volume":"62","author":"Fang","year":"2023","journal-title":"Redox Biol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.cmet.2018.06.002","article-title":"Etomoxir actions on regulatory and memory T cells are independent of Cpt1a-mediated fatty acid oxidation","volume":"28","author":"Raud","year":"2018","journal-title":"Cell Metab"},{"key":"B110","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B111","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/ni.3439","article-title":"Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and Malignancy","volume":"17","author":"Swamy","year":"2016","journal-title":"Nat Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/cas.12484","article-title":"TET2 as an epigenetic master regulator for normal and Malignant hematopoiesis","volume":"105","author":"Nakajima","year":"2014","journal-title":"Cancer Sci"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/nature23475","article-title":"Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism","volume":"548","author":"Xu","year":"2017","journal-title":"Nature"},{"key":"B114","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ni.2556","article-title":"Antigen receptor control of amino acid transport coordinates the metabolic re-programming that is essential for T cell differentiation","volume":"14","author":"Sinclair","year":"2013","journal-title":"Nat Immunol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1073\/pnas.1714717115","article-title":"Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells","volume":"115","author":"Kono","year":"2018","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B116","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mam.2008.05.005","article-title":"Regulation of glutathione synthesis","volume":"30","author":"Lu","year":"2008","journal-title":"Mol Aspects Med"},{"key":"B117","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s13046-023-02845-4","article-title":"Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity","volume":"42","author":"Zheng","year":"2023","journal-title":"J Exp Clin Cancer Res CR"},{"key":"B118","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.03.004","article-title":"Glutathione restricts serine metabolism to preserve regulatory T cell function","volume":"31","author":"Kurniawan","year":"2020","journal-title":"Cell Metab"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.03.019","article-title":"Glutathione primes T cell metabolism for inflammation","volume":"46","author":"Mak","year":"2017","journal-title":"Immunity"},{"key":"B120","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1158\/0008-5472.CAN-19-1577","article-title":"Dysregulation of glutamate transport enhances treg function that promotes VEGF blockade resistance in glioblastoma","volume":"80","author":"Long","year":"2020","journal-title":"Cancer Res"},{"key":"B121","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.celrep.2015.09.036","article-title":"Preventing allograft rejection by targeting immune metabolism","volume":"13","author":"Lee","year":"2015","journal-title":"Cell Rep"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2023.04.006","article-title":"Modulation of T cells by tryptophan metabolites in the kynurenine pathway","volume":"44","author":"Stone","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2020.1765165","article-title":"Discovery of secondary sulphonamides as IDO1 inhibitors with potent antitumour effects in vivo","volume":"35","author":"Ge","year":"2020","journal-title":"J Enzyme Inhib Med Chem"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1038\/nri1457","article-title":"IDO expression by dendritic cells: tolerance and tryptophan catabolism","volume":"4","author":"Mellor","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130066","article-title":"Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4","volume":"210","author":"Holmgaard","year":"2013","journal-title":"J Exp Med"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2021.05.018","article-title":"Blockade of IDO-kynurenine-ahR axis ameliorated colitis-associated colon cancer via inhibiting immune tolerance","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2272","article-title":"First-in-human phase I study of the oral inhibitor of indoleamine 2,3-dioxygenase-1 epacadostat (INCB024360) in patients with advanced solid Malignancies","volume":"23","author":"Beatty","year":"2017","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1038\/s41467-018-04366-7","article-title":"Single cell analysis of kynurenine and System L amino acid transport in T cells","volume":"9","author":"Sinclair","year":"2018","journal-title":"Nat Commun"},{"key":"B129","doi-asserted-by":"publisher","first-page":"103734","DOI":"10.1016\/j.ebiom.2021.103734","article-title":"Kynurenine induces T cell fat catabolism and has limited suppressive effects in vivo","volume":"74","author":"Siska","year":"2021","journal-title":"EBioMedicine"},{"key":"B130","doi-asserted-by":"publisher","first-page":"798S","DOI":"10.3945\/an.115.011221","article-title":"Leucine metabolism in T cell activation: mTOR signaling and beyond","volume":"7","author":"Ananieva","year":"2016","journal-title":"Adv Nutr"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-00816-x","article-title":"The immunology of rheumatoid arthritis","volume":"22","author":"Weyand","year":"2021","journal-title":"Nat Immunol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00018-022-04563-0","article-title":"Regulatory T cells in rheumatoid arthritis: functions, development, regulation, and therapeutic potential","volume":"79","author":"Yan","year":"2022","journal-title":"Cell Mol Life Sci CMLS"},{"key":"B133","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s10875-011-9542-6","article-title":"Combined treatment of etanercept and MTX reverses Th1\/Th2, Th17\/Treg imbalance in patients with rheumatoid arthritis","volume":"31","author":"Lina","year":"2011","journal-title":"J Clin Immunol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-1984-x","article-title":"Disturbed Th17\/Treg balance in patients with rheumatoid arthritis","volume":"32","author":"Niu","year":"2012","journal-title":"Rheumatol Int"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1094872","article-title":"Automated clustering reveals CD4+ T cell subset imbalances in rheumatoid arthritis","volume":"14","author":"Mulhearn","year":"2023","journal-title":"Front Immunol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2005.01656.x","article-title":"The presence of cytokine-suppressive CD4+CD25+ T cells in the peripheral blood and synovial fluid of patients with rheumatoid arthritis","volume":"62","author":"Liu","year":"2005","journal-title":"Scand J Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2005.02754.x","article-title":"CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis","volume":"140","author":"M\u00f6tt\u00f6nen","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1186\/ar1192","article-title":"CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease","volume":"6","author":"Cao","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1080\/03009740701482800","article-title":"Accumulation of FoxP3-expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis","volume":"36","author":"Jiao","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/ar4545","article-title":"CD4+CD25+\/highCD127low\/\u2013 regulatory T cells are enriched in rheumatoid arthritis and osteoarthritis joints\u2013analysis of frequency and phenotype in synovial membrane, synovial fluid and peripheral blood","volume":"16","author":"Moradi","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402990","article-title":"Polyfunctional, pathogenic CD161+ Th17 lineage cells are resistant to regulatory T cell-mediated suppression in the context of autoimmunity","volume":"195","author":"Basdeo","year":"2015","journal-title":"J Immunol Baltim Md"},{"key":"B142","first-page":"58","article-title":"Sirolimus selectively increases circulating Treg cell numbers and restores the Th17\/Treg balance in rheumatoid arthritis patients with low disease activity or in DAS28 remission who previously received conventional disease-modifying anti-rheumatic drugs","volume":"38","author":"Niu","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1312919","article-title":"Augmenting regulatory T cells: new therapeutic strategy for rheumatoid arthritis","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B144","article-title":"Influence of anti-tumor necrosis factor therapy (Adalimumab) on regulatory T cells and dendritic cells in rheumatoid arthritis","volume":"24","author":"Dombrecht","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cellimm.2008.05.007","article-title":"CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis","volume":"253","author":"Han","year":"2008","journal-title":"Cell Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3109\/08916930903061491","article-title":"Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to disease activity score-28","volume":"42","author":"Sempere-Ortells","year":"2009","journal-title":"Autoimmunity"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110283","article-title":"CD4+CD25(high)CD127(low\/-) Treg cell frequency from peripheral blood correlates with disease activity in patients with rheumatoid arthritis","volume":"38","author":"Kawashiri","year":"2011","journal-title":"J Rheumatol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1002\/art.40430","article-title":"Increased circulating follicular treg cells are associated with lower levels of autoantibodies in patients with rheumatoid arthritis in stable remission","volume":"70","author":"Liu","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130252","article-title":"Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells","volume":"210","author":"Yang","year":"2013","journal-title":"J Exp Med"},{"key":"B150","doi-asserted-by":"publisher","first-page":"331ra38","DOI":"10.1126\/scitranslmed.aad7151","article-title":"Restoring oxidant signaling suppresses pro-arthritogenic T-cell effector functions in rheumatoid arthritis","volume":"8","author":"Yang","year":"2016","journal-title":"Sci Transl Med"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024048","article-title":"IL-17A expression is localised to both mononuclear and polymorphonuclear synovial cell infiltrates","volume":"6","author":"Moran","year":"2011","journal-title":"PloS One"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002202","article-title":"Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions","volume":"13","author":"Haas","year":"2015","journal-title":"PloS Biol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.intimp.2013.03.020","article-title":"Metformin downregulates Th17 cells differentiation and attenuates murine autoimmune arthritis","volume":"16","author":"Kang","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0296-7","article-title":"N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation","volume":"20","author":"Wen","year":"2019","journal-title":"Nat Immunol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb6296","article-title":"B cells polarize pathogenic inflammatory T helper subsets through ICOSL-dependent glycolysis","volume":"6","author":"Zeng","year":"2020","journal-title":"Sci Adv"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00063-6","article-title":"Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances","volume":"20","author":"Bar-Or","year":"2021","journal-title":"Lancet Neurol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-052920-040318","article-title":"The immune response in multiple sclerosis","volume":"17","author":"Mur\u00faa","year":"2022","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2209944120","article-title":"Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound","volume":"120","author":"Janoschka","year":"2023","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B159","doi-asserted-by":"publisher","first-page":"121930","DOI":"10.1016\/j.biomaterials.2022.121930","article-title":"Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients","volume":"292","author":"Tredicine","year":"2023","journal-title":"Biomaterials"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2010.01.014","article-title":"Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis","volume":"24","author":"Murphy","year":"2010","journal-title":"Brain Behav Immun"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901881","article-title":"CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis","volume":"183","author":"Fletcher","year":"2009","journal-title":"J Immunol Baltim Md"},{"key":"B162","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ Regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J Exp Med"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.20522","article-title":"Decreased FOXP3 levels in multiple sclerosis patients","volume":"81","author":"Huan","year":"2005","journal-title":"J Neurosci Res"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2006.03271.x","article-title":"Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients","volume":"147","author":"Feger","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2567.2007.02690.x","article-title":"Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level","volume":"123","author":"Venken","year":"2008","journal-title":"Immunology"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2009.06.011","article-title":"Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4+CD25+FOXP3+CD31+ T-cells in patients with multiple sclerosis","volume":"216","author":"Haas","year":"2009","journal-title":"J Neuroimmunol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2006.09.012","article-title":"Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: An ex vivo and in vitro longitudinal study in relapsing\u2013remitting multiple sclerosis","volume":"182","author":"Andr\u00e9s","year":"2007","journal-title":"J Neuroimmunol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"102647","DOI":"10.1016\/j.autrev.2020.102647","article-title":"The role of TH17 cells in multiple sclerosis: Therapeutic implications","volume":"19","author":"Moser","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B169","doi-asserted-by":"publisher","first-page":"170ra15","DOI":"10.1126\/scitranslmed.3004970","article-title":"In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling","volume":"5","author":"Schneider","year":"2013","journal-title":"Sci Transl Med"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1303257","article-title":"Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6","volume":"194","author":"Bhela","year":"2015","journal-title":"J Immunol Baltim Md"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aao5563","article-title":"Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects","volume":"11","author":"Klotz","year":"2019","journal-title":"Sci Transl Med"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201948223","article-title":"Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients","volume":"49","author":"Biasi","year":"2019","journal-title":"Eur J Immunol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41467-023-36594-x","article-title":"Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming","volume":"14","author":"Aso","year":"2023","journal-title":"Nat Commun"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cell.2020.02.035","article-title":"Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism","volume":"180","author":"Duscha","year":"2020","journal-title":"Cell"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.701626","article-title":"Propionic acid rescues high-fat diet enhanced immunopathology in autoimmunity via effects on Th17 responses","volume":"12","author":"Haase","year":"2021","journal-title":"Front Immunol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kww120","article-title":"Causal effect of genetic variants associated with body mass index on multiple sclerosis susceptibility","volume":"185","author":"GianFrancesco","year":"2017","journal-title":"Am J Epidemiol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003849","article-title":"Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS","volume":"88","author":"GianFrancesco","year":"2017","journal-title":"Neurology"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet Lond Engl"},{"key":"B179","doi-asserted-by":"publisher","first-page":"107184","DOI":"10.1016\/j.phrs.2024.107184","article-title":"Metabolic regulation of the Th17\/Treg balance in inflammatory bowel disease","volume":"203","author":"Zhang","year":"2024","journal-title":"Pharmacol Res"},{"key":"B180","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070663","article-title":"Phenotypic and functional features of human Th17 cells","volume":"204","author":"Annunziato","year":"2007","journal-title":"J Exp Med"},{"key":"B182","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1038\/s41467-021-22164-6","article-title":"Single-cell analyses of Crohn\u2019s disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions","volume":"12","author":"Jaeger","year":"2021","journal-title":"Nat Commun"},{"key":"B183","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clim.2003.09.013","article-title":"Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice","volume":"110","author":"Ogawa","year":"2004","journal-title":"Clin Immunol Orlando Fla"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1736","article-title":"A protective function for interleukin 17A in T cell-mediated intestinal inflammation","volume":"10","author":"O\u2019Connor","year":"2009","journal-title":"Nat Immunol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.08.019","article-title":"Differential roles for interleukin-23 and interleukin-17 in intestinal immunoregulation","volume":"43","author":"Maxwell","year":"2015","journal-title":"Immunity"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2017.97","article-title":"Mucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation","volume":"11","author":"Li","year":"2018","journal-title":"Mucosal Immunol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1038\/ng.175","article-title":"Genome-wide association defines more than 30 distinct susceptibility loci for Crohn\u2019s disease","volume":"40","author":"Barrett","year":"2008","journal-title":"Nat Genet"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2016.1214961","article-title":"Peripheral and intestinal T-regulatory cells are upregulated in children with inflammatory bowel disease at onset of disease","volume":"45","author":"Sznurkowska","year":"2016","journal-title":"Immunol Invest"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21159","article-title":"Randomized, double-blind, placebo-controlled trial of the oral interleukin-12\/23 inhibitor apilimod mesylate for treatment of active Crohn\u2019s disease","volume":"16","author":"Sands","year":"2010","journal-title":"Inflammation Bowel Dis"},{"key":"B190","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.immuni.2015.06.024","article-title":"Growth factor FGF2 cooperates with interleukin-17 to repair intestinal epithelial damage","volume":"43","author":"Song","year":"2015","journal-title":"Immunity"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-020-00451-w","article-title":"Clinical trials of IL-12\/IL-23 inhibitors in inflammatory bowel disease","volume":"34","author":"Almradi","year":"2020","journal-title":"BioDrugs Clin Immunother Biopharm Gene Ther"},{"key":"B192","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.cytogfr.2022.07.005","article-title":"The involvement of TH17 cells in the pathogenesis of IBD","volume":"69","author":"Jiang","year":"2023","journal-title":"Cytokine Growth Factor Rev"},{"key":"B193","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.3390\/nu15102275","article-title":"Gut microbial metabolite butyrate and its therapeutic role in inflammatory bowel disease: A literature review","volume":"15","author":"Recharla","year":"2023","journal-title":"Nutrients"},{"key":"B194","doi-asserted-by":"publisher","first-page":"114763","DOI":"10.1016\/j.biopha.2023.114763","article-title":"Short chain fatty acids, a possible treatment option for autoimmune diseases","volume":"163","author":"Golpour","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20903","article-title":"Low counts of Faecalibacterium prausnitzii in colitis microbiota","volume":"15","author":"Sokol","year":"2009","journal-title":"Inflammation Bowel Dis"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-304833","article-title":"A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis","volume":"63","author":"Machiels","year":"2014","journal-title":"Gut"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306571","article-title":"Butyrate prevents the pathogenic anemia-inflammation circuit by facilitating macrophage iron export","volume":"11","author":"Xiao","year":"2024","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2019.11.159","article-title":"An orally administered butyrate-releasing xylan derivative reduces inflammation in dextran sulphate sodium-induced murine colitis","volume":"156","author":"Zha","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"B200","doi-asserted-by":"publisher","first-page":"105420","DOI":"10.1016\/j.phrs.2021.105420","article-title":"The role of short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis","volume":"165","author":"Liu","year":"2021","journal-title":"Pharmacol Res"},{"key":"B201","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1053\/j.gastro.2019.07.025","article-title":"Metabolic functions of gut microbes associate with efficacy of tumor necrosis factor antagonists in patients with inflammatory bowel diseases","volume":"157","author":"Aden","year":"2019","journal-title":"Gastroenterology"},{"key":"B202","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/ajg.2015.149","article-title":"Fecal microbiota in pediatric inflammatory bowel disease and its relation to inflammation","volume":"110","author":"Kolho","year":"2015","journal-title":"Off J Am Coll Gastroenterol ACG"},{"key":"B203","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.clim.2004.05.004","article-title":"Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease","volume":"113","author":"Wolf","year":"2004","journal-title":"Clin Immunol Orlando Fla"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900291","article-title":"Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis","volume":"184","author":"Ciorba","year":"2010","journal-title":"J Immunol Baltim Md"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031131","article-title":"Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease","volume":"7","author":"Hisamatsu","year":"2012","journal-title":"PloS One"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy103","article-title":"Tryptophan metabolism through the kynurenine pathway is associated with endoscopic inflammation in ulcerative colitis","volume":"24","author":"Sofia","year":"2018","journal-title":"Inflammation Bowel Dis"},{"key":"B207","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.1038\/s41467-023-43211-4","article-title":"Dietary L-Tryptophan consumption determines the number of colonic regulatory T cells and susceptibility to colitis via GPR15","volume":"14","author":"Van","year":"2023","journal-title":"Nat Commun"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.44","article-title":"Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature","volume":"106","author":"Hou","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"B209","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.cgh.2016.12.036","article-title":"High dietary intake of specific fatty acids increases risk of flares in patients with ulcerative colitis in remission during treatment with aminosalicylates","volume":"15","author":"Barnes","year":"2017","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2022.09.016","article-title":"Inhibition of pyruvate dehydrogenase kinase 4 in CD4+ T cells ameliorates intestinal inflammation","volume":"15","author":"Lee","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c01856","article-title":"Discovery of novel sesquiterpene lactone derivatives as potent PKM2 activators for the treatment of ulcerative colitis","volume":"66","author":"Wang","year":"2023","journal-title":"J Med Chem"},{"key":"B212","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","article-title":"Systemic lupus erythematosus: A review","volume":"331","author":"Siegel","year":"2024","journal-title":"JAMA"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2010.06.018","article-title":"Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells","volume":"35","author":"Scheinecker","year":"2010","journal-title":"J Autoimmun"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker116","article-title":"Recovery of the immune balance between Th17 and regulatory T cells as a treatment for systemic lupus erythematosus","volume":"50","author":"Yang","year":"2011","journal-title":"Rheumatol Oxf Engl"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2014.12.027","article-title":"Th1\/Th2\/Th17\/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity","volume":"72","author":"Talaat","year":"2015","journal-title":"Cytokine"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13012","article-title":"Altered frequency of Th17 and Treg cells in new-onset systemic lupus erythematosus patients","volume":"48","author":"Chen","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00391","article-title":"Altered th17\/treg ratio in peripheral blood of systemic lupus erythematosus but not primary antiphospholipid syndrome","volume":"10","author":"\u00c1lvarez-Rodr\u00edguez","year":"2019","journal-title":"Front Immunol"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken108","article-title":"and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus","volume":"47","author":"Lee","year":"2008","journal-title":"Rheumatol Oxf Engl"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12208","article-title":"Evaluation of the immunomodulatory effect of melatonin on the T-cell response in peripheral blood from systemic lupus erythematosus patients","volume":"58","author":"Medrano-Campillo","year":"2015","journal-title":"J Pineal Res"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01027","article-title":"T cell metabolism: A new perspective on th17\/treg cell imbalance in systemic lupus erythematosus","volume":"11","author":"Shan","year":"2020","journal-title":"Front Immunol"},{"key":"B221","doi-asserted-by":"publisher","first-page":"274ra18","DOI":"10.1126\/scitranslmed.aaa0835","article-title":"Normalization of CD4+ T cell metabolism reverses lupus","volume":"7","author":"Yin","year":"2015","journal-title":"Sci Transl Med"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1172\/JCI120859","article-title":"Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted","volume":"128","author":"Tilstra","year":"2018","journal-title":"J Clin Invest"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.242","article-title":"Kidney-infiltrating CD4+ T-cell clones promote nephritis in lupus-prone mice","volume":"82","author":"Okamoto","year":"2012","journal-title":"Kidney Int"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301859","article-title":"Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus","volume":"192","author":"Kato","year":"2014","journal-title":"J Immunol Baltim Md"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301005","article-title":"Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus","volume":"191","author":"Lai","year":"2013","journal-title":"J Immunol Baltim Md"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1002\/art.42840","article-title":"Phosphatidic acid promoting the generation of interleukin-17A producing double-negative T cells by enhancing mTORC1 signaling in lupus","volume":"76","author":"Li","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"B227","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1172\/JCI22854","article-title":"Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV","volume":"115","author":"Juang","year":"2005","journal-title":"J Clin Invest"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1002\/art.40785","article-title":"Promotion of calcium\/calmodulin-dependent protein kinase 4 by GLUT1-dependent glycolysis in systemic lupus erythematosus","volume":"71","author":"Koga","year":"2019","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201785","article-title":"Calcium\/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupus","volume":"189","author":"Koga","year":"2012","journal-title":"J Immunol Baltim Md"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1172\/JCI73411","article-title":"CaMK4-dependent activation of AKT\/mTOR and CREM-\u03b1 underlies autoimmunity-associated Th17 imbalance","volume":"124","author":"Koga","year":"2014","journal-title":"J Clin Invest"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.593103","article-title":"Enhanced fatty acid synthesis leads to subset imbalance and IFN-\u03b3 Overproduction in T helper 1 cells","volume":"11","author":"Iwata","year":"2020","journal-title":"Front Immunol"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-002-0216-9","article-title":"Serum leptin levels in women with systemic lupus erythematosus","volume":"22","author":"Garcia-Gonzalez","year":"2002","journal-title":"Rheumatol Int"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.142737","article-title":"High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids","volume":"70","author":"McMahon","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1607101113","article-title":"Louren\u00e7o, Aijing Liu, Giuseppe Matarese, Antonio La Cava. Leptin promotes systemic lupus erythematosus by increasing autoantibody production and inhibiting immune regulation","volume":"113","author":"Elaine","year":"2016","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B235","doi-asserted-by":"publisher","first-page":"114498","DOI":"10.1016\/j.ejmech.2022.114498","article-title":"Contemporary mTOR inhibitor scaffolds to diseases breakdown: a patent review (2015-2021)","volume":"238","author":"Oleksak","year":"2022","journal-title":"Eur J Med Chem"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30485-9","article-title":"Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial","volume":"391","author":"Lai","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2006.01.044","article-title":"Side effects of sirolimus","volume":"38","author":"Merkel","year":"2006","journal-title":"Transplant Proc"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.07.006","article-title":"Efficacy and safety of sirolimus in patients with systemic lupus erythematosus: A systematic review and meta-analysis","volume":"50","author":"Ji","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.806560","article-title":"The role of immunometabolism in the pathogenesis of systemic lupus erythematosus","volume":"12","author":"Robinson","year":"2021","journal-title":"Front Immunol"},{"key":"B240","doi-asserted-by":"publisher","first-page":"7684352","DOI":"10.1155\/2019\/7684352","article-title":"Low-dose sirolimus immunoregulation therapy in patients with active rheumatoid arthritis: A 24-week follow-up of the randomized, open-label, parallel-controlled trial","volume":"2019","author":"Wen","year":"2019","journal-title":"J Immunol Res"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000273","article-title":"Pharmacodynamic monitoring of mammalian target of rapamycin inhibition by phosphoflow cytometric determination of p70S6 kinase activity","volume":"99","author":"Hoerning","year":"2015","journal-title":"Transplantation"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12603","article-title":"Different in vitro proliferation and cytokine-production inhibition of memory T-cell subsets after calcineurin and mammalian target of rapamycin inhibitors treatment","volume":"148","author":"Merino","year":"2016","journal-title":"Immunology"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.3390\/ijms13021886","article-title":"The mTOR signalling pathway in human cancer","volume":"13","author":"P\u00f3pulo","year":"2012","journal-title":"Int J Mol Sci"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.078808","article-title":"Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study","volume":"67","author":"Bruyn","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"B245","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/mrcr\/rxac033","article-title":"A mechanistic target of rapamycin inhibitor, everolimus safely ameliorated lupus nephritis in a patient complicated with tuberous sclerosis","volume":"7","author":"Okita","year":"2023","journal-title":"Mod Rheumatol Case Rep"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.02024.x","article-title":"A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn\u2019s disease","volume":"103","author":"Reinisch","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2014.01.040","article-title":"mTOR inhibition: A promising strategy for stabilization of atherosclerotic plaques","volume":"233","author":"Martinet","year":"2014","journal-title":"Atherosclerosis"},{"key":"B248","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3390\/ijms24010755","article-title":"Metformin and its immune-mediated effects in various diseases","volume":"24","author":"Nojima","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B249","doi-asserted-by":"publisher","first-page":"107575","DOI":"10.1016\/j.intimp.2021.107575","article-title":"The AMPK modulator metformin as adjunct to methotrexate in patients with rheumatoid arthritis: A proof-of-concept, randomized, double-blind, placebo-controlled trial","volume":"95","author":"Abdallah","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1002\/art.39296","article-title":"Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin","volume":"67","author":"Wang","year":"2015","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30004-7","article-title":"Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"2","author":"Sun","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"B252","doi-asserted-by":"publisher","first-page":"107362","DOI":"10.1016\/j.intimp.2020.107362","article-title":"Metformin and omega-3 fish oil elicit anti-inflammatory effects via modulation of some dysregulated micro RNAs expression and signaling pathways in experimental induced arthritis","volume":"92","author":"El-Sayyad","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B253","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1089\/ars.2013.5702","article-title":"Increased mitochondrial electron transport chain activity at complex I is regulated by N-acetylcysteine in lymphocytes of patients with systemic lupus erythematosus","volume":"21","author":"Doherty","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-015-0772-0","article-title":"Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin","volume":"11","author":"Perl","year":"2015","journal-title":"Metabolomics Off J Metabolomic Soc"},{"key":"B255","doi-asserted-by":"publisher","DOI":"10.1002\/art.34502","article-title":"N-Acetylcysteine Reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial","volume":"64","author":"Lai","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2017.03.010","article-title":"Induction of colonic regulatory T cells by mesalamine by activating the aryl hydrocarbon receptor","volume":"4","author":"Oh-Oka","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.1155\/S0962935192000243","article-title":"Mechanism of action of 5-arninosalicylic acid","volume":"1","author":"Punchard","year":"1992","journal-title":"Mediators Inflammation"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00698.x","article-title":"Colorectal cancer prevention in ulcerative colitis: a case-control study","volume":"14","author":"Eaden","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(18)30231-0","article-title":"Comparative efficacy and tolerability of pharmacological agents for management of mild to moderate ulcerative colitis: a systematic review and network meta-analyses","volume":"3","author":"Nguyen","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab010","article-title":"Ford. Efficacy of oral, topical, or combined oral and topical 5-aminosalicylates, in ulcerative colitis: systematic review and network meta-analysis","volume":"15","author":"Barberio","year":"2021","journal-title":"J Crohns Colitis"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2022.06.003","article-title":"Emerging mechanisms and applications of low-dose IL-2 therapy in autoimmunity","volume":"67","author":"Zhou","year":"2022","journal-title":"Cytokine Growth Factor Rev"},{"key":"B263","article-title":"Cytokines and the chronic inflammation of rheumatic disease. III. Deficient interleukin-2 production in rheumatoid arthritis is not due to suppressor mechanisms","volume":"14","author":"Nouri","year":"1987","journal-title":"J Rheumatol"},{"key":"B264","article-title":"Deficient interleukin 2 production in rheumatoid arthritis: association with active disease and systemic complications","volume":"73","author":"Kitas","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"B265","doi-asserted-by":"publisher","first-page":"740619","DOI":"10.1155\/2010\/740619","article-title":"The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity","volume":"2010","author":"Lieberman","year":"2010","journal-title":"J BioMed Biotechnol"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207776","article-title":"Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus","volume":"75","author":"Spee-Mayer","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214229","article-title":"Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial","volume":"78","author":"Rosenzwajg","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215396","article-title":"Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial","volume":"79","author":"He","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.41451","article-title":"Efficacy and safety of low-dose interleukin 2 for primary sj\u00f6gren syndrome: A randomized clinical trial","volume":"5","author":"He","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.947341","article-title":"Low-dose IL-2 improved clinical symptoms by restoring reduced regulatory T cells in patients with refractory rheumatoid arthritis: A randomized controlled trial","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222501","article-title":"Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial","volume":"81","author":"Humrich","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B272","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12865-019-0305-0","article-title":"Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17\/Treg cells in refractory SLE patients","volume":"20","author":"Zhao","year":"2019","journal-title":"BMC Immunol"},{"key":"B273","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2165\/00003495-200767001-00002","article-title":"Atorvastatin: pharmacological characteristics and lipid-lowering effects","volume":"67","author":"Poli","year":"2007","journal-title":"Drugs"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet Lond Engl"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202442","article-title":"Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study","volume":"73","author":"McInnes","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202315","article-title":"Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein","volume":"73","author":"Ardoin","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.1002\/art.40892","article-title":"A multicenter, randomized, placebo-controlled trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis","volume":"71","author":"Kitas","year":"2019","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"B278","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M010876","article-title":"Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis","volume":"52","author":"Tang","year":"2011","journal-title":"J Lipid Res"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000319698.40024.1c","article-title":"Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis","volume":"71","author":"Birnbaum","year":"2008","journal-title":"Neurology"},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.1177\/1352458509358909","article-title":"Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy","volume":"16","author":"Lanzillo","year":"2010","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"B281","doi-asserted-by":"publisher","DOI":"10.1177\/1352458508091368","article-title":"Atorvastatin decreases high-sensitivity C-reactive protein in multiple sclerosis","volume":"14","author":"Sellner","year":"2008","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6513-7","article-title":"Atorvastatin added to interferon \u03b2 for relapsing multiple sclerosis: a randomized controlled trial","volume":"259","author":"Kamm","year":"2012","journal-title":"J Neurol"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2014.10.004","article-title":"Atorvastatin calcium in combination with methylprednisolone for the treatment of multiple sclerosis relapse","volume":"23","author":"Li","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.05.009","article-title":"Diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms","volume":"15","author":"Choi","year":"2016","journal-title":"Cell Rep"},{"key":"B285","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ebiom.2018.08.057","article-title":"Ketogenic diets attenuate cyclooxygenase and lipoxygenase gene expression in multiple sclerosis","volume":"36","author":"Bock","year":"2018","journal-title":"EBioMedicine"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001102","article-title":"Impact of dietary intervention on serum neurofilament light chain in multiple sclerosis","volume":"9","author":"Bock","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B287","doi-asserted-by":"publisher","first-page":"2300602","DOI":"10.1002\/mnfr.202300602","article-title":"A high MCT-based ketogenic diet suppresses th1 and th17 responses to ameliorate experimental autoimmune encephalomyelitis in mice by inhibiting GSDMD and JAK2-STAT3\/4 pathways","volume":"68","author":"Zhang","year":"2024","journal-title":"Mol Nutr Food Res"},{"key":"B288","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3390\/nu15030579","article-title":"Dietary exposures and interventions in inflammatory bowel disease: current evidence and emerging concepts","volume":"15","author":"Gubatan","year":"2023","journal-title":"Nutrients"},{"key":"B289","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12385","article-title":"Food avoidance and fasting in patients with inflammatory bowel disease: Experience from the Nancy IBD nutrition clinic","volume":"11","author":"Bonsack","year":"2023","journal-title":"United Eur Gastroenterol J"},{"key":"B290","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.3390\/nu16223956","article-title":"Effect of intermittent fasting on immune parameters and intestinal inflammation","volume":"16","author":"Haasis","year":"2024","journal-title":"Nutrients"},{"key":"B291","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1043783","article-title":"Time-restricted feeding ameliorates dextran sulfate sodium-induced colitis via reducing intestinal inflammation","volume":"9","author":"Song","year":"2022","journal-title":"Front Nutr"},{"key":"B292","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1016\/j.celrep.2019.02.019","article-title":"Fasting-mimicking diet modulates microbiota and promotes intestinal regeneration to reduce inflammatory bowel disease pathology","volume":"26","author":"Rangan","year":"2019","journal-title":"Cell Rep"},{"key":"B293","doi-asserted-by":"publisher","first-page":"108785","DOI":"10.1016\/j.jnutbio.2021.108785","article-title":"Intermittent administration of a fasting-mimicking diet reduces intestinal inflammation and promotes repair to ameliorate inflammatory bowel disease in mice","volume":"96","author":"Song","year":"2021","journal-title":"J Nutr Biochem"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c05732","article-title":"An engineered butyrate-derived polymer nanoplatform as a mucosa-healing enhancer potentiates the therapeutic effect of magnolol in inflammatory bowel disease","volume":"18","author":"Fan","year":"2024","journal-title":"ACS Nano"},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3808","article-title":"Metabolic control of the scaffold protein TKS5 in tissue-invasive, proinflammatory T cells","volume":"18","author":"Shen","year":"2017","journal-title":"Nat Immunol"},{"key":"B296","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2019.1695928","article-title":"Adherence to metformin and the onset of rheumatoid arthritis: a population-based cohort study","volume":"49","author":"Naffaa","year":"2020","journal-title":"Scand J Rheumatol"},{"key":"B297","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.12.054","article-title":"Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis","volume":"138","author":"Sandborn","year":"2010","journal-title":"Gastroenterology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1687755\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T05:17:42Z","timestamp":1765862262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1687755\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":297,"alternative-id":["10.3389\/fimmu.2025.1687755"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1687755","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"article-number":"1687755"}}